Systematic Review and Meta-Analysis of Randomized, Controlled Trials on Preoperative Physical Exercise Interventions in Patients with Non-Small-Cell Lung Cancer

被引:98
|
作者
Rosero, Ilem D. [1 ]
Ramirez-Velez, Robinson [1 ]
Lucia, Alejando [2 ,3 ,4 ]
Martinez-Velilla, Nicolas [1 ,4 ]
Santos-Lozano, Alejandro [2 ,5 ]
Valenzuela, Pedro L. [6 ]
Morilla, Idoia [1 ]
Izquierdo, Mikel [1 ,4 ]
机构
[1] Univ Publ Navarra, Navarrabiomed Biomed Res Ctr, IDISNA Navarras Hlth Res Inst, Dept Hlth Sci, C Irunlarrea 3,Complejo Hosp Navarra, Pamplona 31008, Navarra, Spain
[2] Hosp 12 Octubre I 12, Res Inst, Madrid 28670, Spain
[3] Univ Europea Madrid, Fac Sport Sci, Madrid 28670, Spain
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid 28029, Spain
[5] European Univ Miguel de Cervantes, Dept Hlth Sci, I HeALTH, Valladolid 47012, Spain
[6] Univ Alcala, Dept Syst Biol, Madrid 28805, Spain
关键词
resistance training; cardiovascular; functional capacity; lung cancer; OBSTRUCTIVE PULMONARY-DISEASE; REHABILITATION PROGRAM; OXYGEN-CONSUMPTION; ELDERLY-PATIENTS; RESECTION; COMPLICATIONS; SURGERY; CHEMOTHERAPY; CAPACITY; SURVIVAL;
D O I
10.3390/cancers11070944
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Preoperative physical exercise protocols prior to cancer surgery increased in popularity over recent years; however, the beneficial effect of such protocols is not well established, with conflicting results reported. We conducted a systematic review and meta-analysis of randomized controlled trials (RCTs) to assess the effects of different modalities or combinations of preoperative exercise interventions and/or prehabilitation multicomponent training in patients with non-small-cell lung cancer (NSCLC) after surgery on the outcomes related to functional capacity, mental wellness and medical care. We searched in OVID Embase, Pubmed, Cochrane Library, CINAHL, Scopus, and Web of Science. Characteristics of studies and program results and outcome data were extracted. Changes between the intervention and control groups, from baseline to follow-up (standardized mean difference (SMD) or relative risk (RR) with 95% confidence interval (CI) for each intervention was pooled using weighted random-effects models). A total of 676 participants from 10 RCTs were included in the final analysis (aerobic training + inspiratory muscle training, n = 5; aerobic training + strength training + inspiratory muscle training, n = 2; aerobic training + strength training, n = 1; multicomponent training, n = 1; aerobic training alone, n = 1). The results showed intervention-induced improvement in walking endurance (SMD = 0.27; 95% CI, 0.11 to 0.44; I-2 = 0.0%), peak exercise capacity (SMD = 0.78; 95% CI, 0.35 to 1.21; I-2 = 76.7%), dyspnoea (SMD = -0.30; 95% CI, -0.51 to -0.10; I-2 = 0.0%), risk of hospitalization (SMD = -0.58; 95% CI, -0.97 to -0.20; I-2 = 70.7%), and postoperative pulmonary complications (relative risk (RR) = 0.50; 95% CI, 0.39 to 0.66; I-2 = 0.0%). For the functional capacity and medical care parameters, preoperative combined aerobic, resistance, and inspiratory muscle training was shown to be effective if comprising one to four weeks, performing 1-3 sessions per week, with moderate intensity (50% for endurance capacity). Further studies with larger samples and higher methodological quality are needed to clarify the potential benefits of preoperative exercise training for patients with NSCLC.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis
    Nishie, Kenichi
    Yamamoto, Shuhei
    Nagata, Chie
    Koizumi, Tomonobu
    Hanaoka, Masayuki
    LUNG CANCER, 2017, 112 : 25 - 34
  • [42] Adoptive Immunotherapy in Postoperative Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Zeng, Yuan
    Ruan, Wenli
    He, Jiaxi
    Zhang, Jianrong
    Liang, Wenhua
    Chen, Yaoqi
    He, Qihua
    He, Jianxing
    PLOS ONE, 2016, 11 (09):
  • [43] Anlotinib for refractory advanced non-small-cell lung cancer: A systematic review and meta-analysis
    Yu, Guocan
    Shen, Yanqin
    Xu, Xudong
    Zhong, Fangming
    PLOS ONE, 2020, 15 (11):
  • [44] Efficacy and safety of cemiplimab in non-small-cell lung cancer: systematic review and meta-analysis
    Subroto, D. R. T.
    Budiman, R. A.
    Subroto, Dion R. T.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1377 - S1377
  • [45] Gefitinib versus docetaxel in previously treated advanced non-small-cell lung cancer: A meta-analysis of randomized controlled trials
    Jiang, Jingwei
    Huang, Lizhen
    Liang, Xiaohua
    Zhou, Xinli
    Huang, Ruofan
    Chu, Zhaohui
    Zhan, Qiong
    ACTA ONCOLOGICA, 2011, 50 (04) : 582 - 588
  • [46] Efficacy and safety of docetaxel for advanced non-small-cell lung cancer: a meta-analysis of Phase III randomized controlled trials
    He, Xuan
    Wang, Ji
    Li, Yuanmin
    ONCOTARGETS AND THERAPY, 2015, 8 : 2023 - 2031
  • [47] The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Bi, Guoshu
    Yao, Guangyu
    Bian, Yunyi
    Xue, Liang
    Zhang, Yi
    Lu, Tao
    Fan, Hong
    ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 26 (01) : 1 - 12
  • [48] Compound Kushen Injection as an Adjunctive Therapy for the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials
    Pu, Liu
    Chen, Wei-hao
    Cao, Lu-xi
    Wu, Kun-ji
    Chen, Shu-lian
    Lin, Ji-huan
    Li, Cheng-lu
    Wang, Shi-qi
    Zhu, Ming-min
    Zhang, Yi-min
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2019, 2019
  • [49] Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis
    Mell, Loren K.
    Malik, Renuka
    Komaki, Ritsuko
    Movsas, Benjamin
    Swann, R. Suzanne
    Langer, Corey
    Antonadou, Dosia
    Koukourakis, Michael
    Mundt, Arno J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 68 (01): : 111 - 118
  • [50] The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials
    Tian, Rong-Hua
    Wu, Xia
    Liu, Xia
    Yang, Jin-Wang
    Ji, Hua-Liang
    Yan, Yong-Jin
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (02) : 571 - 575